⌘+K

Pulse Explore Communities Researchers Journals

Home Communities Explore

July 29, 2019Annals of Internal MedicineOpen Access

Sodium–Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections

Chintan V. Dave Sebastian Schneeweiß Dae Hyun Kim Michael Fralick Angela Tong Elisabetta Patorno

View Full Paper

Ask AI

Bookmark

Share

No abstract yet

We only have this paper's title and publication details.

Read it at the source→

Abstract

Brigham and Women's Hospital, Division of Pharmacoepidemiology and Pharmacoeconomics.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Dave et al. (2019) studied this question.

synapsesocial.com/papers/69d979b1387cf706986842b7 https://doi.org/10.7326/m18-3136

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1The Mechanisms and Therapeutic Potential of SGLT2 Inhibitors in Diabetes MellitusOriginal Research · 2014 · 348 citations
2Sodium–Glucose Cotransporter 2 Inhibitors for Type 2 DiabetesRisk Assessment · 2013 · 911 citations
3Canagliflozin and Cardiovascular and Renal Events in Type 2 DiabetesRandomized Controlled Trial · 2017 · 7,826 citations
4Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort studyRetrospective Study · 2018 · 173 citations
5Empagliflozin and Progression of Kidney Disease in Type 2 DiabetesOriginal Research · 2016 · 3,655 citations

Lower Risk of Heart Failure and Death in Patients Initiated on Sodium-Glucose Cotransporter-2 Inhibitors Versus Other Glucose-Lowering Drugs2017
Effect of glucose and pH on uropathogenic and non-uropathogenic Escherichia coli: studies with urine from diabetic and non-diabetic individuals1999
Urinary tract and genital infections in patients with type 2 diabetes treated with sodium‐glucose co‐transporter 2 inhibitors: A meta‐analysis of randomized controlled trials2016
Impact of Unrestricted Artificial Intelligence Scribe Deployment in a Single Health System on Clinician Workload and ProductivityAnnals of Internal Medicine · 2026
The Hidden Human Costs of Ambient ScribesAnnals of Internal Medicine · 2026

More from Annals of Internal Medicine

More from Harvard University

More from Brigham and Women's Hospital